Catabasis Pharma To Report First Quarter 2016 Financial Results And Recent Corporate Developments On Thursday, May 12

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report first quarter 2016 financial results after the NASDAQ Global Market close on Thursday, May 12, 2016. Jill C. Milne, Ph.D., Chief Executive Officer, will host a conference call and webcast at 4:30pm ET to provide an update on corporate developments and to discuss first quarter financial results.